Organoids have rapidly become revolutionary tools in biomedical research, transforming approaches to drug discovery and disease modeling. These three-dimensional cell culture models have the...
Patient-derived organoids (PDOs), including those from tumors, are implemented as predictive models of patient responses to drugs and therapies. Incorporation of the BioAssembly™ platform...
